Gattefossé Pharmaceuticals

❓Quiz time!

Have you met our team at American Association of Pharmaceutical Scientists (AAPS) | @aapscomms ? Last chance to talk about our ingredients with them at booth #1702 #Pharmaceuticals #Formulation #ExcipientInnovation #Gattefosse

Are you developing a sustained-release tablet? Want to easily adjust your dissolution profile? Compritol® 888 ATO can do it! ✨ 👉 Acts as modified release agent with diffusion-driven drug release 👉 Easily adjust release profiles based on Compritol®’s concentration 👉 Can be used in hot processes such as melt granulation and hot melt extrusion, and cold processes such as wet granulation and direct compression 👉 Resists physiological changes in pH 👉 Has global precedence of use in marketed products (including Pediatric!) For more information about Compritol® 888 ATO, check out the product page at https://lnkd.in/dq8Cc56t and reach out to your account representative! #gattefossé #pharmaceuticals

Join Inayet Dumanli-Ellis, Ph.D, Ketkee Deshmukh, Ph.D. and Andrew Schultz, M.S. for this live webinar. 👩🔬 Lipid-based matrices are versatile because they are resistant to invivo conditions including changes in physiological pH, digestion, and alcohol exposure. They can be used in different processes in-cluding direct compression, wet granulation and melt extrusion. This webinar will explore Compritol® 888 ATO (glyceryl dibehenate) release mechanisms, case studies with advanced formulation techniques, key insights into formulation development, and strategies to ensure robust and stable drug delivery systems. Register today! 👉 https://lnkd.in/drw8pHuE

We will be at AAPS from the 20 to 23rd of October. You can join us for two poster presentations: 👩🔬 Elise Dauphin Chanard, our Laboratory Manager Pharmaceuticals at our headquarters will present: Improving the in vitro in vivo correlation of lipid formulations using a simplified gastro-intestinal lipolysis protocol. October 21st - 2.30pm 👩🔬 Ketkee Deshmukh, our Head technical Pharmaceuticals in India will present: Platform Technology for introducing liquid solubilisers in tablet formulations. October 22nd - 11.30am #gattefossé #aaps #pharmaceuticals  

We are waiting for you CPHI Worldwide in Milan, Italy at booth 6D50! Join us to discuss your formulation needs and how we can provide assistance with any development challenges you are having. #gattefossé #pharmaceuticals #cphi

On September 25, 2024, the Gattefossé USA Pharmaceutical team hosted around 30 customers at the Hilton Garden Inn in Waltham, MA for an in-person educational seminar. This one-day workshop covered mitigation of the risk of formulation development failures using Self-Emulsifying Drug Delivery Systems (SEDDS) with drugs facing bioavailability challenges, lipids’ physicochemical and biopharmaceutical properties, and enhancement of API solubility and oral bioavailability. The seminar began with opening remarks from Rollie Fuller, Technical Sales Representative, and continued throughout the day with technical presentations given by Dr. Inayet Dumanli-Ellis, Ph.D, Scientific Affairs Director, Dr. Masumi Dave, Application Laboratory Manager, and Andrew Schultz, Sales Manager. These presentations covered a range of topics from selecting right vehicles to maximize bioavailability to overcoming permeability challenges with SEDDS. Thank you to all attendees for a successful event! #Gattefossé #pharmaceuticals #events

Register to our webinar: Sustained Release Redefined: Lipid-Based Matrices – a Versatile Platform 👉 Friday, October 25, 2024, from 2:00–3:00 pm EDT This webinar will explore Compritol® 888 ATO (glyceryl dibehenate) release mechanisms, case studies with advanced formulation techniques, key insights into formulation development, and strategies to ensure robust and stable drug delivery systems. With Inayet Dumanli-Ellis, Ph.D, Ketkee Deshmukh, Andrew Schultz #gattefossé #pharmaceuticals #webinar

Next week we will be at CPHI Worldwide in Milan, Italy at booth 6D50! Join us to discuss your formulation needs and how we can provide assistance with any development challenges you are having. It is also the opportunity to learn more about our new manufacturing plant in Lufkin, Texas! 🏭 Schedule your meetings with us now: https://lnkd.in/d9pDvAn3 hashtag#gattefossé hashtag#pharmaceuticals hashtag#CPHI

Transcutol® P is a highly effective solubilizer and penetration enhancer for topical applications. In the past, Gattefossé has studied the effect of Transcutol® P as a penetration enhancer in neat and diluted mixtures. In Gattefossé’s new review article “Skin Penetration and Permeation Properties of Transcutol® in Complex Formulations”, Jasmine Musakhanian, David Osborne, and Jean-David Rodier review and discuss the role of Transcutol® P in complex formulations, including patches, gels, foams, solid lipid nanoparticles and nano-lipid carriers, and micro- and nanoemulsions. Check out the publication here: https://lnkd.in/d-UAYmCR #pharmaceuticals #Gattefossé